MICRONEEDLE-BASED TRANSDERMAL INSULIN DELIVERY: A NOVEL DRUG DELIVERY APPROACH

Diabetes mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels due to insufficient insulin production or impaired insulin action. Conventional insulin administration mainly involves subcutaneous injections, which may cause pain, discomfort, needle fear, and difficulties in maintaining proper blood glucose control. To overcome these limitations, micro needle-based transdermal drug delivery has emerged as a promising alternative for insulin administration. Microneedles are micronized structures designed to penetrate the outer skin barrier and create microscopic pathways for drug delivery. This review focuses on microneedle patches for transdermal insulin delivery in diabetes management. It discusses the different types of microneedles, including solid, hollow, coated, dissolving, hydrogel, and biodegradable microneedles, along with their materials and manufacturing methods. The mechanism of insulin release from different polymeric microneedle systems, advantages, challenges, and limitations are also discussed. Furthermore, clinical readiness and safety aspects are highlighted. Microneedle patches offer potential benefits such as minimally invasive administration, improved patient convenience, and controlled insulin delivery. However, further research is required to improve their drug loading capacity, mechanical strength, insulin stability, and long-term safety. Overall, microneedle-based patches represent a promising approach for the future of transdermal insulin delivery in diabetes management. Furthermore, this review highlights the role of different polymeric microneedle systems in insulin release,including dissolvable, nanoparticle-loaded, bio-erodible, and hydrogel microneedles. It also emphasizes the importance of suitable materials and fabrication techniques for improving drug delivery performance. Although microneedle technology shows considerable potential, further research and clinical studies are needed to overcome existing limitations and support its future clinical application.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24414828
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

MICRONEEDLE-BASED TRANSDERMAL INSULIN DELIVERY: A NOVEL DRUG DELIVERY APPROACH

Aishwarya Deshmukh, Sakshi Anil Raut, Rahul S. Bijwar, Krutika Sanjay Bisen et al.
Zenodo (CERN European Organization for Nuclear Research)
Advancements in Transdermal Drug Delivery
article

MICRONEEDLE-BASED TRANSDERMAL INSULIN DELIVERY: A NOVEL DRUG DELIVERY APPROACH

Aishwarya Deshmukh, Sakshi Anil Raut, Rahul S. Bijwar, Krutika Sanjay Bisen, Simran Yunus Sheikh
article en

Abstract

Diabetes mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels due to insufficient insulin production or impaired insulin action. Conventional insulin administration mainly involves subcutaneous injections, which may cause pain, discomfort, needle fear, and difficulties in maintaining proper blood glucose control. To overcome these limitations, micro needle-based transdermal drug delivery has emerged as a promising alternative for insulin administration. Microneedles are micronized structures designed to penetrate the outer skin barrier and create microscopic pathways for drug delivery. This review focuses on microneedle patches for transdermal insulin delivery in diabetes management. It discusses the different types of microneedles, including solid, hollow, coated, dissolving, hydrogel, and biodegradable microneedles, along with their materials and manufacturing methods. The mechanism of insulin release from different polymeric microneedle systems, advantages, challenges, and limitations are also discussed. Furthermore, clinical readiness and safety aspects are highlighted. Microneedle patches offer potential benefits such as minimally invasive administration, improved patient convenience, and controlled insulin delivery. However, further research is required to improve their drug loading capacity, mechanical strength, insulin stability, and long-term safety. Overall, microneedle-based patches represent a promising approach for the future of transdermal insulin delivery in diabetes management. Furthermore, this review highlights the role of different polymeric microneedle systems in insulin release,including dissolvable, nanoparticle-loaded, bio-erodible, and hydrogel microneedles. It also emphasizes the importance of suitable materials and fabrication techniques for improving drug delivery performance. Although microneedle technology shows considerable potential, further research and clinical studies are needed to overcome existing limitations and support its future clinical application.

Zenodo (CERN European Organization for Nuclear Research)
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
MICRONEEDLE-BASED TRANSDERMAL INSULIN DELIVERY: A NOVEL DRUG DELIVERY APPROACH — Aishwarya Deshmukh, Sakshi Anil Raut, et al. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS